B. Braun Medical Inc. is recalling 30,672 units of Heparin Sodium Injection (25,000 USP units per 250 mL) in 5% Dextrose. This medication, which is used to prevent and treat blood clots, is being recalled because it was found to be subpotent, meaning it does not contain the required amount of the active ingredient to be fully effective. No incidents or injuries have been reported to date regarding this issue.
If the medication is subpotent, it may not provide enough anticoagulation to effectively prevent or treat blood clots. This failure could lead to serious medical conditions, including deep vein thrombosis, pulmonary embolism, or stroke.
Recall #: D-0434-2023
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.